AstraZeneca’s speculative vaccine is probably the world’s prominent prospect and most advanced in regards to advancement.

Favorable news on preliminary trials of the University of Oxford’s capacity COVID-19 vaccine that has been licensed to AstraZeneca could be revealed as soon as Thursday, ITV’s political editor Robert Peston stated, mentioning a source.

The potential vaccine is currently in large-scale Phase III human trials to evaluate whether it can protect against COVID-19, however its developers have yet to report Phase I results which would reveal whether it is safe and whether it causes an immune reaction.

Also read: Serum Institute may produce 2-3 million Oxford vaccine doses in July

The designers of the vaccine stated this month they were encouraged by the immune action they had seen in trials so far and were expecting to publish Ph